Supplemental Experimental Procedures

Supplemental protein expression and purification
Plasmids were transformed into E. coli BL21 (DE3) CodonPlus RIL competent cells [2] by heat shock at 42 °C, 1 min, 0 °C, 5 min and then incubation in 1 mL 2xTY media at 37 °C, 30 min. These were then plated on TYE (Kanamycin 25 µg/mL) agar plates and grown overnight at 37 °C. Single colonies were then grown in starter cultures of 2× 50 mL LB media (Kanamycin 25 µg/mL) on a shaker at 37 °C overnight. From these 20x 1 L 2xTY expression media (Kanamycin 25 µg/mL) were inoculated at 1:100 volume dilution and grown at 37 °C to an OD 600 of 0.6 -0.8. The temperature was lowered to 20 °C and overnight expression was induced with IPTG (1 mM final concentration). Cells were harvested by centrifugation (5,000 rpm, 15 min, 4 °C) and pellets were either frozen at -20 °C for future purification or were resuspended in lysis buffer (20 mM Tris.HCl pH 8.0, 200 mM NaCl, 2 mM β-mercaptoethanol).
To resuspended cell pellets were added PMSF (1 mM) and 2 anti-protease tablets (Roche) before lysis by sonication while keeping samples on ice. 0.04% Bovine DNase I (Sigma Aldrich), 0.1% Mn 2+ and 1% Mg 2+ were then added to the lysate on ice, before separation of the cell debris by centrifugation (20,000 rpm, 30 min, 4 °C).
Further clarification was performed through 0.22 µm syringe filters (Sartorius) and these clarified lysates were added to a glass column containing Nickel NTA agarose resin (Qiagen, 2.5 mL of 50% slurry per litre of culture) pre-equilibrated with buffer The purified protein fractions were collected and analysed for purity by SDS-PAGE (using standard PAGE protocols) and those deemed to be >95% pure were pooled and concentrated to 200 µM (as assessed by Nanodrop) using 30 kDa cut-off Amicon Ultra concentrator tubes (Millipore). Average protein yield was ~10 mg/L and mass spectrometry showed a molecular weight of 50435 ± 90 Da consistent with untagged ΔIBB-importin-α1. The protein was flash-frozen in liquid nitrogen in 100 or 200 µL aliquots in thin-wall PCR tubes before storing at -80 °C. Each aliquot was defrosted fully prior to use.
All experiments, competitive and direct, were run using the optimised experiment conditions: 20 injections (first volume 1 µL subsequent 2 µL with default durations), reference power 5 -7 µCal/sec, initial delay 60 sec, stirring speed 1000 rpm, spacing 90 sec and filter period of 2 sec. Experiment injection of 39 µL titrant into 250 µL of protein solution over 40 min.
Co-crystallisation attempts
A screen for co-crystallisation conditions of unliganded mouse ΔIBB-importin-α1 with fragments 1 -10 was set up in the MRC-LMB using in-house robotic nanolitre crystallisation methods on 96-well plates as described by Stock et al. [3] . Once capped, the finished peptide was washed with 5× DMF, 5× DCM and dried before cleaving with concomitant global deprotection with 4 mL 95% TFA in water (v/v) for 3 hr at room temperature. Resin was washed with a further 2 mL 95% TFA in water before the majority of TFA was evaporated under a nitrogen stream. The peptide was precipitated with ice-cold diethyl ether overnight and collected by centrifugation before washing with 3× cold diethyl ether to give the crude peptide which was then lyophilised overnight before purification by HPLC. Product peaks were isolated and lyophilised overnight giving the product.
Standard Procedure B) Suzuki couplings
1 eq. of each boronic acid and bromide starting material were combined in a microwave vial (Biotage) and dissolved in DME before the addition of potassium carbonate (2 eq.) dissolved in water (3:1 v/v DME/water). Nitrogen was bubbled through the stirring solution before the addition of Pd(dppf)Cl 2 (0.04 eq.) and sealing the vial. The reaction was heated in a Biotage Initiator Microwave Synthesizer at o C for 2 hr unless otherwise stated. The majority of DME was removed in vacuo before addition of sat. sodium bicarbonate solution and extraction with 3× EtOAc.
The combined organics were then dried with anhydrous magnesium sulphate, filtered and the solvent was removed in vacuo to give the crude compound, which was then purified as described. 
Tert-butyl (S)-(6-amino-6-oxo-5-((4-(pyridin-3-yl)benzyl)amino)hexyl)carbamate
[5] A solution of Methyl N 6 -(tert-butoxycarbonyl)-N 2 -(4-(pyridin-3-yl)benzyl)-L-
(S)-6-Amino-2-((4-(pyridin-3-yl)benzyl)amino)hexanamide 11
Tert-butyl (S)-(6-amino-6-oxo-5-((4-(pyridin-3-yl)benzyl)amino)hexyl)carbamate (170 mg, 0.41 mmol) was dissolved in 4 M HCl in dioxane (15 mL) and stirred for 3 hr at room temperature. The reaction was reduced in vacuo to give the crude compound, which was further purified by HPLC as described in Section 5.5.1. Product fractions eluted at 9 min and were lyophilised to afford the TFA salt of the pyridine lysine amide 11 as an orange solid (63 mg, 49% yield).
HPLC elution at 9 min, purity >95%; ν max. 3400 cm -1 (N-H), 1698 cm -1 (C=O); 
Tert-butyl N 6 -(tert-butoxycarbonyl)-N 2 -(4-(pyridin-3-yl)benzyl)-L-lysinate
(4-(Pyridin-3-yl)benzyl)-L-lysine Tert-butyl N 6 -(tert-butoxycarbonyl)-N 2 -(4-(pyridin-3-yl)benzyl)-L-
(S)-6-Amino-N-(2-(((2S,3R)-1-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-2-oxoethyl)-2-((4-(pyridin-3-yl)benzyl)amino)
hexanamide 12 Kaiser test suggested capping was complete, and the resin was cleaved and purified by HPLC using the conditions described in Procedure A. Lyophilisation of product containing fractions gave the peptide 12 as a white fluffy solid (45 mg, 80% yield).
HPLC elution 6 min, purity >95%; ν max. 3600 -3150 cm -1 (N-H), 1640 cm (w/v, 25 mL) before the organic layer was dried over anhydrous sodium sulphate, filtered and reduced in vacuo to give the protected serinate [7] as a white amorphous solid (3.5 g, 93% yield). [7] .
Benzyl trityl-L-serinate (890 mg, 2.03 mmol), 3-(bromomethyl)pyridine hydrobromide (514 mg, 2.03 mmol) and tetrabutylammonium bromide (654 mg, 2.03 mmol) were combined in a solution of toluene (7 mL) and 40% NaOH (2 mL) before being stirred at room temperature for 36 hr. Water (14 mL) was added to the reaction mixture before extracting with EtOAc (3× 20 mL). The combined organics were dried over anhydrous sodium sulphate, filtered and reduced in vacuo. The crude product was purified using column chromatography (Biotage, 15 -100% EtOAc/petroleum ether, v/v) to give the pyridine serinate as a white amorphous solid (586 mg, 55% yield). 
Benzyl O-(pyridin-3-ylmethyl)-L-serinate
Benzyl O-(pyridin-3-ylmethyl)-N-trityl-L-serinate (100 mg, 0.19 mmol) was dissolved in 20% TFA in DCM (v/v, 4 mL) and stirred at room temperature for 2 hr. The reaction mixture was reduced in vacuo to give crude product as the TFA salt, which was dissolved in water (4 mL) and extracted with EtOAc (3× 5 mL) before basifying the aqueous to pH 9 and extracting with EtOAc again (3× 5 mL). The basic extracts were dried over anhydrous sodium sulphate, filtered and reduced in vacuo to give the pyridine serinate as a colourless oil (44 mg, 79% yield). 
Benzyl N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(pyridin-3-ylmethyl)-L-serinate
To 
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-(pyridin-3-ylmethyl)-L-serine
(S)-2-Acetamido-6-amino-N-((S)-1-(((2S,3R)-1-(((S)-1-amino-1-oxo-3-phenylpropan-
2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-1-oxo-3-(pyridin-3-ylmethoxy)propan-
2-yl)hexanamide 13
Following Standard Procedure A for solid-phase peptide synthesis and starting with 100 mg Rink amide resin, the following amounts of amino acids were reacted for the times below: give the pyridine aldehyde [8] as a yellow oil (189 mg, 63% yield). [8] .
i 0.04 eq Pd(dppf)Cl 2 , 2 eq K 2 CO 3 , DME:water ( Product containing fractions were reduced in vacuo to give the Fmoc-D-lysine [9] as a white solid (555 mg, 97% yield). Data were consistent with those previously reported by Watts et al. [9] . [10] (9H-Fluoren-9-yl)methyl tert-butyl (6-amino-6-oxohexane-1,5-diyl)(R) were combined and reacted as described above. The crude product was purified by column chromatography (Biotage, eluent 20 -100% EtOAc/petroleum ether v/v) to
-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N 6 -(tert-butoxycarbonyl)-D-lysine To a solution of H-D-Lys(Boc)-OH
R F (10% MeOH/DCM v/v) =(9H-Fluoren-9-yl)methyl tert-butyl (6-amino-6-oxohexane-1,5-diyl)(R)-dicarbamate
Tert-Butyl (R)-(6-amino-6-oxo-5-((4-(pyridin-3-yl)benzyl)amino)hexyl)carbamate
-
Tert-butyl (S)-(6-amino-6-oxo-5-((3-(pyridin-3-yl)benzyl)amino)hexyl)carbamate
give the pyridine carbaldehyde [11] as a yellow solid (165 mg, 55% yield). 
